Adient $ADNT Shares Bought by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund raised its holdings in Adient (NYSE:ADNTFree Report) by 179.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 527,356 shares of the company’s stock after acquiring an additional 338,517 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Adient were worth $10,658,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Vanguard Group Inc. raised its stake in shares of Adient by 4.7% in the fourth quarter. Vanguard Group Inc. now owns 4,684,882 shares of the company’s stock valued at $89,809,000 after acquiring an additional 208,938 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Adient by 5.1% in the first quarter. Dimensional Fund Advisors LP now owns 4,384,904 shares of the company’s stock valued at $88,614,000 after purchasing an additional 211,843 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in Adient by 17.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company’s stock worth $46,349,000 after purchasing an additional 336,306 shares in the last quarter. UBS Group AG grew its stake in Adient by 12.9% during the 4th quarter. UBS Group AG now owns 1,848,690 shares of the company’s stock worth $35,439,000 after purchasing an additional 210,758 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in Adient by 38.6% during the 4th quarter. Invesco Ltd. now owns 1,599,937 shares of the company’s stock worth $30,671,000 after purchasing an additional 445,343 shares during the period. Institutional investors and hedge funds own 92.44% of the company’s stock.

Insider Activity

In other news, EVP Heather M. Tiltmann sold 22,000 shares of the company’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $22.71, for a total value of $499,620.00. Following the completion of the transaction, the executive vice president owned 110,886 shares in the company, valued at approximately $2,518,221.06. This represents a 16.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.94% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on ADNT. Stifel Nicolaus reduced their price target on Adient from $28.00 to $26.00 and set a “buy” rating on the stock in a research report on Monday, July 20th. UBS Group upped their target price on shares of Adient from $33.00 to $34.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Adient from $31.00 to $29.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Citigroup raised shares of Adient from a “neutral” rating to a “buy” rating and increased their price objective for the company from $30.00 to $33.00 in a research report on Wednesday, April 15th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Adient from $28.00 to $26.00 and set a “neutral” rating on the stock in a report on Thursday, April 23rd. Five research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $28.11.

View Our Latest Stock Report on Adient

Adient Price Performance

ADNT stock opened at $21.57 on Wednesday. The business has a 50 day moving average price of $20.82 and a 200 day moving average price of $21.61. The company has a quick ratio of 0.91, a current ratio of 1.10 and a debt-to-equity ratio of 1.18. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 30.38, a PEG ratio of 0.40 and a beta of 1.53. Adient has a fifty-two week low of $17.68 and a fifty-two week high of $27.32.

Adient (NYSE:ADNTGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.44 by $0.08. Adient had a net margin of 0.39% and a return on equity of 7.28%. The company had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.62 billion. During the same period in the prior year, the firm posted $0.69 earnings per share. The firm’s revenue was up 7.0% on a year-over-year basis. Equities research analysts anticipate that Adient will post 2.13 earnings per share for the current fiscal year.

About Adient

(Free Report)

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.

Further Reading

Want to see what other hedge funds are holding ADNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adient (NYSE:ADNTFree Report).

Institutional Ownership by Quarter for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.